GlycoNex Competitors and Similar CompaniesClear all
GlycoNex's competitors and similar companies include Oncopeptides.
 GlycoNex GlycoNex (台灣醣聯生技醫藥股) is a company developing cancer drugs utilizing glycosphingolipid antigen and human monoclonal antibody technologies. | ||
Founding Date | Founding Date 2001 | Founding Date 2000 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations TW HQ | Locations Stockholm, SE HQ Stockholm, SE Los Altos, US Mountain View, US Waltham, US |
Employees | Employees N/A | Employees 80 |
Financial | ||
Revenue (est.) | Revenue (est.) NT$37.9m (FY, 2025) | Revenue (est.) kr71.1m (FY, 2025) |
Cost of goods | Cost of goods NT$14.3m (FY, 2025) | Cost of goods kr2.5m (FY, 2025) |
Gross profit | Gross profit NT$36.7m (FY, 2025) | Gross profit kr72m (FY, 2025) |
Net income | Net income (NT$235.2m) (FY, 2025) | Net income (kr249.6m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Oncopeptides
HQ
Stockholm, SE
Employees
80
Oncopeptides is a clinical development pharmaceutical company.
View company